CliffBio
small molecule

CORDRAN

FLURANDRENOLIDE

Loss of exclusivity—loss of exclusivity
CompanyAlmirall →See this company's full patent-cliff portfolio

Drug detail

Brand nameCORDRAN
Active ingredientFLURANDRENOLIDE
Strength0.004MG/SQ CM
Dosage formTAPE
RouteTOPICAL
ModalitySmall molecule
Marketing statusRX

More from Almirall

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CORDRAN patent cliff — loss of exclusivity — | CliffBio